Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • MWMidwife
  • NPNurse Practitioner
  • OPOptometrist
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 8115D CABERGOLINEcabergoline 500 microgram tablet, 2 1 2 0
MPNP 8394T CABERGOLINEcabergoline 2 mg tablet, 30 1 30 5
MPNP 8393R CABERGOLINEcabergoline 1 mg tablet, 30 1 30 5
MPNP 10075G CALCIPOTRIOL + BETAMETHASONE DIPROPIONATEcalcipotriol 0.005% + betamethasone (as dipropionate) 0.05% gel, 60 g 1 1 1
MPNP 11091R CALCIPOTRIOL + BETAMETHASONE DIPROPIONATEcalcipotriol 0.005% + betamethasone (as dipropionate) 0.05% foam, 60 g 1 1 1
MPNP 9494Q CALCIPOTRIOL + BETAMETHASONE DIPROPIONATEcalcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 30 g 1 1 1
MPNP 2997R CALCITONIN SALMON (SALCATONIN)calcitonin salmon (salcatonin) 100 units/mL injection, 5 x 1 mL ampoules 3 15 5
MPNP 2502Q CALCITRIOLcalcitriol 0.25 microgram capsule, 100 1 100 3
MPNP 3116B CALCIUMCALCIUM Tablet (chewable) 500 mg (as carbonate), 60 4 240 1
MPNP 3117C CALCIUMCALCIUM Tablet 600 mg (as carbonate), 240 1 240 1
MPNP 8297Q CANDESARTANcandesartan cilexetil 16 mg tablet, 30 1 30 5
MPNP 8889W CANDESARTANcandesartan cilexetil 32 mg tablet, 30 1 30 5
MPNP 8296P CANDESARTANcandesartan cilexetil 8 mg tablet, 30 1 30 5
MPNP 8295N CANDESARTANcandesartan cilexetil 4 mg tablet, 30 1 30 5
MPNP 9314F CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 9315G CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 32 mg + hydrochlorothiazide 25 mg tablet, 30 1 30 5
MPNP 8504N CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 1149L CAPTOPRILcaptopril 50 mg tablet, 90 1 90 5
MPNP 1148K CAPTOPRILcaptopril 25 mg tablet, 90 1 90 5
MPNP 1147J CAPTOPRILcaptopril 12.5 mg tablet, 90 1 90 5
MPNP 8760C CAPTOPRILcaptopril 5 mg/mL oral liquid, 95 mL 1 1 5
MPNP 2422L CARBAMAZEPINEcarbamazepine 100 mg tablet, 100 2 200 2
MPNP 1706T CARBAMAZEPINEcarbamazepine 200 mg tablet, 100 2 200 2
MPNP 2431Y CARBAMAZEPINEcarbamazepine 400 mg modified release tablet, 200 1 200 2
MPNP 2427R CARBAMAZEPINEcarbamazepine 100 mg/5 mL oral liquid, 300 mL 1 1 5
MPNP 2426Q CARBAMAZEPINEcarbamazepine 200 mg modified release tablet, 200 1 200 2
MPNP 1153Q CARBIMAZOLEcarbimazole 5 mg tablet, 100 2 200 2
MPNP 8369L CARBOHYDRATE, FAT, VITAMINS, MINERALS AND TRACE ELEMENTScarbohydrate, fat, vitamins, minerals and trace elements powder for oral liquid, 400 g 8 8 5
MPNP 10039J CARBOHYDRATES, FAT, VITAMINS, MINERALS, TRACE ELEMENTS AND SUPPLEMENTED WITH ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACIDcarbohydrates, fat, vitamins, minerals, trace elements and supplemented with arachidonic acid and docosahexaenoic acid providing 200 kilocalories powder for oral liquid, 30 x 43 g sachets 4 4 5
MPNP 8514D CARBOMER-974carbomer-974 0.3% eye gel, 30 x 500 mg unit doses 3 3 5
MPNP 8578L CARBOMER-980carbomer-980 0.2% eye drops, 30 x 0.6 mL unit doses 3 3 5
MPNP 8384G CARBOMER-980carbomer-980 0.2% eye gel, 10 g 1 1 5
MPNP 8593G CARMELLOSE SODIUMcarmellose sodium 1% eye drops, 15 mL 1 1 5
MPNP 8548X CARMELLOSE SODIUMcarmellose sodium 0.5% eye drops, 15 mL 1 1 5
MPNP 2324H CARMELLOSE SODIUMcarmellose sodium 1% eye drops, 30 x 0.4 mL unit doses 3 3 5
MPNP 2338C CARMELLOSE SODIUMcarmellose sodium 0.5% eye drops, 30 x 0.4 mL unit doses 3 3 5
MPNP 9355J CARMELLOSE SODIUM + GLYCEROLcarmellose sodium 0.5% + glycerol 0.9% eye drops, 15 mL 1 1 3
MPNP 8256M CARVEDILOLcarvedilol 6.25 mg tablet, 60 1 60 5
MPNP 8255L CARVEDILOLcarvedilol 3.125 mg tablet, 30 1 30 0
MPNP 8258P CARVEDILOLcarvedilol 25 mg tablet, 60 1 60 5
MPNP 8257N CARVEDILOLcarvedilol 12.5 mg tablet, 60 1 60 5
MPMWNP 3058Y CEFALEXINcefalexin 250 mg capsule, 20 1 20 1
MPMWNP 3119E CEFALEXINcefalexin 500 mg capsule, 20 1 20 1
MPNP 3095X CEFALEXINcefalexin 250 mg/5 mL powder for oral liquid, 100 mL 1 1 1
MPNP 3094W CEFALEXINcefalexin 125 mg/5 mL powder for oral liquid, 100 mL 1 1 1
MPNP 2964B CEFALOTINcefalotin 1 g injection, 10 vials 1 10 1
MPNP 1257E CEFAZOLINcefazolin 1 g injection, 10 vials 1 10 0
MPNP 5478H CEFAZOLINcefazolin 1 g injection, 10 vials 1 10 0
MPNP 1797N CEFAZOLINcefazolin 1 g injection, 5 vials 2 10 0
MPNP 1799Q CEFAZOLINcefazolin 1 g injection, 5 vials 2 10 0
MPNP 5479J CEFAZOLINcefazolin 2 g injection, 1 vial 10 10 0
MPNP 9326W CEFAZOLINcefazolin 2 g injection, 1 vial 10 10 0
MPNP 1256D CEFAZOLINcefazolin 500 mg injection, 5 vials 2 10 0
MPNP 5477G CEFAZOLINcefazolin 500 mg injection, 5 vials 2 10 0
MPNP 8315P CEFEPIMECEFEPIME Powder for injection 1 g (as hydrochloride), 1 10 10 0
MPNP 8316Q CEFEPIMECEFEPIME Powder for injection 2 g (as hydrochloride), 1 10 10 0
MPNP 1759N CEFOTAXIMEcefotaxime 2 g injection, 10 vials 1 10 0
MPNP 1758M CEFOTAXIMEcefotaxime 1 g injection, 10 vials 1 10 0
MPNP 1785Y CEFTRIAXONEceftriaxone 2 g injection, 1 vial 5 5 0
MPNP 1783W CEFTRIAXONEceftriaxone 500 mg injection, 1 vial 5 5 0
MPNP 9058R CEFTRIAXONEceftriaxone 500 mg injection, 1 vial 1 1 0
MPNP 1788D CEFTRIAXONEceftriaxone 1 g injection, 5 vials 1 5 0
MPNP 1784X CEFTRIAXONEceftriaxone 1 g injection, 1 vial 5 5 0
MPNP 11169W CEFTRIAXONEceftriaxone 2 g injection, 5 vials 1 5 0
MPNP 8439E CELECOXIBcelecoxib 100 mg capsule, 60 1 60 3
MPNP 8440F CELECOXIBcelecoxib 200 mg capsule, 30 1 30 3
MPMWNPOP 11112W CHLORAMPHENICOLchloramphenicol 0.5% eye drops, 10 mL 1 1 2
MPNP 1195X CHLORPROMAZINEchlorpromazine hydrochloride 50 mg/2 mL injection, 10 x 2 mL ampoules 1 10 0
MPNP 3455W CHLORPROMAZINEchlorpromazine hydrochloride 50 mg/2 mL injection, 10 x 2 mL ampoules 1 10 0
MPNP 1196Y CHLORPROMAZINEchlorpromazine hydrochloride 10 mg tablet, 100 1 100 5
MPNP 1201F CHLORPROMAZINEchlorpromazine hydrochloride 5 mg/mL oral liquid, 100 mL 1 1 5
MPNP 1197B CHLORPROMAZINEchlorpromazine hydrochloride 25 mg tablet, 100 1 100 5
MPNP 1199D CHLORPROMAZINEchlorpromazine hydrochloride 100 mg tablet, 100 1 100 5
MPNP 1585K CHLORTALIDONEchlortalidone 25 mg tablet, 50 2 100 1
MPNP 8854B CICLESONIDEciclesonide 160 microgram/actuation pressurised inhalation, 120 actuations 1 1 5
MPNP 8853Y CICLESONIDEciclesonide 80 microgram/actuation pressurised inhalation, 120 actuations 1 1 5
MPNP 1158Y CIMETIDINEcimetidine 400 mg tablet, 60 1 60 5
MPNP 1209P CIPROFLOXACINciprofloxacin 500 mg tablet, 14 1 14 0
MPNP 1208N CIPROFLOXACINciprofloxacin 250 mg tablet, 14 1 14 0
MPNP 2480M CIPROFLOXACINciprofloxacin 0.3% ear drops, 5 mL 1 1 1
MPNP 1210Q CIPROFLOXACINciprofloxacin 750 mg tablet, 14 1 14 0
MPNP 8702B CITALOPRAMcitalopram 10 mg tablet, 28 1 28 5
MPNP 8220P CITALOPRAMcitalopram 20 mg tablet, 28 1 28 5
MPNP 8703C CITALOPRAMcitalopram 40 mg tablet, 28 1 28 5
MPNP 2091C CITRIC ACID + LAURYL SULFOACETATE SODIUM + SORBITOLsodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema, 12 x 5 mL 2 2 2
MPNP 5331N CITRIC ACID + LAURYL SULFOACETATE SODIUM + SORBITOLsodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema, 12 x 5 mL 2 2 3
MPNP 10736C CITRULLINEcitrulline 1 g tablet, 300 1 1 5
MPNP 5481L CITRULLINE WITH CARBOHYDRATEcitrulline with carbohydrate containing 1 g citrulline oral liquid: powder for, 30 x 4 g sachets 4 4 5
MPNP 8318T CLARITHROMYCINclarithromycin 250 mg tablet, 14 1 14 1
MPNP 9192T CLARITHROMYCINclarithromycin 250 mg/5 mL powder for oral liquid, 50 mL 1 1 0
MPMWNP 3138E CLINDAMYCINclindamycin 150 mg capsule, 24 2 48 1
MPNP 8265B CLODRONATEclodronate sodium 800 mg tablet, 60 1 60 2
MPNP 8132B CLODRONATEclodronate sodium 400 mg capsule, 100 1 100 2
MPNP 1561E CLOMIPRAMINEclomipramine hydrochloride 25 mg tablet, 50 1 50 2
MPNP 11520H CLONAZEPAMclonazepam 500 microgram tablet, 50 2 100 3
MPNP 11559J CLONAZEPAMclonazepam 500 microgram tablet, 50 4 200 2
MPNP 5337X CLONAZEPAMclonazepam 500 microgram tablet, 100 1 100 3
MPNP 1805B CLONAZEPAMclonazepam 500 microgram tablet, 100 2 200 2
MPNP 5338Y CLONAZEPAMclonazepam 2 mg tablet, 100 1 100 3
MPNP 1806C CLONAZEPAMclonazepam 2 mg tablet, 100 2 200 2
MPNP 1808E CLONAZEPAMclonazepam 2.5 mg/mL (0.1 mg/drop) oral liquid, 10 mL 2 2 0
MPNP 3478C CLONAZEPAMclonazepam 2.5 mg/mL (0.1 mg/drop) oral liquid, 10 mL 1 1 0
MPNP 5339B CLONAZEPAMclonazepam 2.5 mg/mL (0.1 mg/drop) oral liquid, 10 mL 2 2 3
MPNP 1807D CLONAZEPAMclonazepam 1 mg/mL injection [5 x 1 mL ampoules] (&) inert substance diluent [5 x 1 mL ampoules], 1 pack 1 5 0
MPNP 3141H CLONIDINEclonidine hydrochloride 150 microgram tablet, 100 1 100 5
MPNP 3145M CLONIDINEclonidine hydrochloride 100 microgram tablet, 100 1 100 5
MPNP 2275R CLOPIDOGRELclopidogrel 75 mg tablet, 28 1 28 5
MPNP 8358X CLOPIDOGRELclopidogrel 75 mg tablet, 28 1 28 5
MPNP 9317J CLOPIDOGRELclopidogrel 75 mg tablet, 28 1 28 5
MPNP 9354H CLOPIDOGRELclopidogrel 75 mg tablet, 28 1 28 5
MPNP 9296G CLOPIDOGREL + ASPIRINclopidogrel 75 mg + aspirin 100 mg tablet, 30 1 30 5
MPNP 1214X CODEINEcodeine phosphate hemihydrate 30 mg tablet, 20 1 20 0
MPNP 3410L COLCHICINEcolchicine 500 microgram tablet, 30 1 30 5
MPNP 2967E COLESTYRAMINEcolestyramine 4 g powder for oral liquid, 50 sachets 2 2 5
MPNP 1246N CORTISONEcortisone acetate 5 mg tablet, 50 1 50 4
MPNP 1247P CORTISONEcortisone acetate 25 mg tablet, 60 1 60 4
MPNP 8334P CROMOGLYCATEsodium cromoglycate 5 mg/actuation pressurised inhalation, 112 actuations 1 1 5
MPNP 8767K CROMOGLYCATEsodium cromoglycate 1 mg/actuation pressurised inhalation, 200 actuations 1 1 5
MPNP 9164H CYSTINE WITH CARBOHYDRATEcystine with carbohydrate containing 500 mg cystine oral liquid: powder for, 30 x 4 g sachets 4 4 5